Walleye Trading LLC Cerevel Therapeutics Holdings, Inc. Call Options Transaction History

Walleye Trading LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$38.96 - $42.75 $23,376 - $25,650	600 Added 0.58%	103,500 $4.23 Million
Q1 2024 May 15, 2024	BUY	$40.88 - $43.27 $28,616 - $30,289	700 Added 0.68%	102,900 $4.35 Million
Q4 2023 Feb 14, 2024	BUY	$20.27 - $42.44 $2.07 Million - $4.34 Million	102,200 New	102,200 $4.33 Million
Q1 2023 May 15, 2023	BUY	$22.82 - $35.32 $171,150 - $264,900	7,500 Added 72.82%	17,800 $434,000
Q4 2022 Feb 14, 2023	BUY	$25.35 - $31.96 $261,105 - $329,188	10,300 New	10,300 $324,000
Q2 2022 Aug 08, 2022	BUY	$20.62 - $37.15 $1.46 Million - $2.64 Million	71,000 New	71,000 $1.88 Million

5.01M

3.3K

Ticker CERE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 155,752,000
Description
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.